A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy-Reference-Cited by-同舟云学术

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy

Published:2020-08 Issue:4 Volume:10 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Zhang Chaoqi¹,Zhang Zhihui¹,Zhang Guochao¹,Xue Liyan²,Yang Haijun³,Luo Yuejun¹,Zheng Xiaoli⁴,Zhang Yonglei⁵,Yuan Yufen³,Lei Ruixue³,Yang Zhaoyang²,Zheng Bo²,Zhang Zhen⁶,Wang Le⁷,Che Yun¹,Wang Sihui¹,Wang Feng¹,Fang Lingling¹,Zeng Qingpeng¹,Li Jiagen¹,Gao Shugeng¹,Xue Qi¹,Sun Nan¹,He Jie¹^ORCID

Affiliation:

1. Department of Thoracic Surgery National Cancer Center National Clinical Research Center for Cancer Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Pathology National Cancer Center National Clinical Research Center for Cancer Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Pathology Anyang Cancer Hospital The Fourth Affiliated Hospital of Henan University of Science and Technology Anyang Henan China

4. Department of radiotherapy The Affiliated Cancer hospital of Zhengzhou University Zhengzhou Henan China

5. Department of General Surgery The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou Henan China

6. Biotherapy Center The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

7. Department of Otology The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Natural Science Foundation of Beijing Municipality

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.156

Reference45 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Epidemiology of Esophageal Squamous Cell Carcinoma

3. Global cancer statistics

4. Esophageal carcinoma advances in treatment results for locally advanced disease: review

5. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective;Pharmacology & Therapeutics;2024-02

2. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance;Pharmacological Research;2023-02

3. Novel defined N7-methylguanosine modification-related lncRNAs for predicting the prognosis of laryngeal squamous cell carcinoma;BIOCELL;2023

4. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer;Pathology and Oncology Research;2022-11-07

5. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma;BioMed Research International;2022-10-25